01.01.05
Padma, a Tibetan herbal formula, which is exclusively distributed in the U.S. by EcoNugenics, Inc., Santa Rosa, CA, has been proven to be effective in promoting circulation and aiding in the treatment of peripheral arterial occlusive diseases (PAOD). Dr. Jörg Melzer from the University of Zurich, Department of Natural Medicine, has unveiled promising results of his systematic review and meta-analysis on the clinical data behind Padma. The six double-blind, placebo-controlled studies consisted of the data from 444 patients (average age of 63; 64% males) diagnosed with stable PAOD Fontaine stage IIb. After four months, patients treated with Padma showed a marked increase in treadmill walking distance.